Delivery Order SPE2DB20D2104-SPE2DB24FT73R
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $7,500.96 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559291100 - Ondansetron ODT 4 mg Tablets. This delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- The federal contract award SPE2DB20D3111|SPE2DB24FA7NU was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,953.32 firm fixed-price delivery order is for the supply of 4,564,478,692 Ondansetron ODT 4 mg tablets, with an ultimate completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,749.82 firm fixed-price delivery order is for the supply of Ondansetron Orally Disintegrating Tablets (ODT) 4mg, 30 count, with a completion date of May 10, 2024. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as Amerisourcebergen) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,179.76, is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 8 mg Tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,321.36, is for the delivery of Ondansetron ODT 8 mg tablets to support medical supply needs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ondansetron HCL 4 mg tablets. The contract, valued at $1,590.86, is a Firm Fixed Price agreement with a completion date of May 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,361.64 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,789,214 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,685.70 firm-fixed-price delivery order is for the supply of 500 units of Ondansetron HCL 4 mg tablets. The award has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award valued at $1,041.90 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Ondansetron ODT 4 mg tablets. The contract is a delivery order under Cencora's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT73RDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 10:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/22/24 |